CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 1
T-cell Receptor-engineered T-cells (T-cell Receptor-engineered T-cells)
Prostate Carcinoma; Prostate Small Cell Neuroendocrine Carcinoma · Metastatic Malignant Solid Neoplasm
#MetastaticMalignantSolidNeoplasm#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 32%임상시험 2상태 RECRUITING